Physician profile

Chavone Dantrell Momon-Nelson

Obstetrics & Gynecology · Carlisle, PA

NPI 1457663106

$10,736.66

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$562.54
Travel and Lodging$476.63
Education$64.95
Gift$8.74

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $10,409.14 2021-2024
Astellas Pharma US INC $105.23 2023-2024 Veozah
Abbvie INC. $77.03 2023
Ethicon US, LLC $55.94 2024 Ethicon, Surgicel Nu-Knit, Evarrest
Merck Sharp & Dohme LLC $42.65 2019-2021
Organon LLC $23.46 2024
Pfizer INC. $17.33 2023
Alydia Health $5.88 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Chavone Dantrell Momon-Nelson

$10,736.66

in general payments reported 2019-2025

Years
2019-2024
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/518708/chavone-dantrell-momon-nelson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.